The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
DNA & RNA Oligonucleotides-Global Market Insights and Sales Trends 2025
Synopsis
The global DNA & RNA Oligonucleotides market size is expected to reach US$ 1477 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of DNA & RNA Oligonucleotides in various end use industries. The expanding demands from the Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Others, are propelling DNA & RNA Oligonucleotides market. DNA Oligonucleotides, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RNA Oligonucleotides segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for DNA & RNA Oligonucleotides market, driven by demand from China, the second largest economy with some signs of stabilising, the DNA & RNA Oligonucleotides market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for DNA & RNA Oligonucleotides, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global DNA & RNA Oligonucleotides market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global DNA & RNA Oligonucleotides market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, DNA & RNA Oligonucleotides sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of DNA & RNA Oligonucleotides covered in this report include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences and Macrogen, etc.
The global DNA & RNA Oligonucleotides market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Genotypic Technology
Dna Link
Global DNA & RNA Oligonucleotides market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global DNA & RNA Oligonucleotides market, Segment by Type:
DNA Oligonucleotides
RNA Oligonucleotides
Global DNA & RNA Oligonucleotides market, by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of DNA & RNA Oligonucleotides companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global DNA & RNA Oligonucleotides market size is expected to reach US$ 1477 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of DNA & RNA Oligonucleotides in various end use industries. The expanding demands from the Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Others, are propelling DNA & RNA Oligonucleotides market. DNA Oligonucleotides, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RNA Oligonucleotides segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for DNA & RNA Oligonucleotides market, driven by demand from China, the second largest economy with some signs of stabilising, the DNA & RNA Oligonucleotides market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for DNA & RNA Oligonucleotides, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global DNA & RNA Oligonucleotides market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global DNA & RNA Oligonucleotides market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, DNA & RNA Oligonucleotides sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of DNA & RNA Oligonucleotides covered in this report include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences and Macrogen, etc.
The global DNA & RNA Oligonucleotides market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Genotypic Technology
Dna Link
Global DNA & RNA Oligonucleotides market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global DNA & RNA Oligonucleotides market, Segment by Type:
DNA Oligonucleotides
RNA Oligonucleotides
Global DNA & RNA Oligonucleotides market, by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of DNA & RNA Oligonucleotides companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of DNA & RNA Oligonucleotides
1.1 DNA & RNA Oligonucleotides Market Overview
1.1.1 DNA & RNA Oligonucleotides Product Scope
1.1.2 DNA & RNA Oligonucleotides Market Status and Outlook
1.2 Global DNA & RNA Oligonucleotides Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global DNA & RNA Oligonucleotides Market Size by Region (2018-2029)
1.4 Global DNA & RNA Oligonucleotides Historic Market Size by Region (2018-2023)
1.5 Global DNA & RNA Oligonucleotides Market Size Forecast by Region (2024-2029)
1.6 Key Regions, DNA & RNA Oligonucleotides Market Size (2018-2029)
1.6.1 North America DNA & RNA Oligonucleotides Market Size (2018-2029)
1.6.2 Europe DNA & RNA Oligonucleotides Market Size (2018-2029)
1.6.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size (2018-2029)
1.6.4 Latin America DNA & RNA Oligonucleotides Market Size (2018-2029)
1.6.5 Middle East & Africa DNA & RNA Oligonucleotides Market Size (2018-2029)
2 DNA & RNA Oligonucleotides Market by Type
2.1 Introduction
2.1.1 DNA Oligonucleotides
2.1.2 RNA Oligonucleotides
2.2 Global DNA & RNA Oligonucleotides Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global DNA & RNA Oligonucleotides Historic Market Size by Type (2018-2023)
2.2.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America DNA & RNA Oligonucleotides Revenue Breakdown by Type (2018-2029)
2.3.2 Europe DNA & RNA Oligonucleotides Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific DNA & RNA Oligonucleotides Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America DNA & RNA Oligonucleotides Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa DNA & RNA Oligonucleotides Revenue Breakdown by Type (2018-2029)
3 DNA & RNA Oligonucleotides Market Overview by Application
3.1 Introduction
3.1.1 Hospitals and Clinics
3.1.2 Biopharma Companies
3.1.3 Academic & Research Organizations
3.1.4 Others
3.2 Global DNA & RNA Oligonucleotides Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global DNA & RNA Oligonucleotides Historic Market Size by Application (2018-2023)
3.2.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America DNA & RNA Oligonucleotides Revenue Breakdown by Application (2018-2029)
3.3.2 Europe DNA & RNA Oligonucleotides Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific DNA & RNA Oligonucleotides Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America DNA & RNA Oligonucleotides Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa DNA & RNA Oligonucleotides Revenue Breakdown by Application (2018-2029)
4 DNA & RNA Oligonucleotides Competition Analysis by Players
4.1 Global DNA & RNA Oligonucleotides Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2022)
4.3 Date of Key Players Enter into DNA & RNA Oligonucleotides Market
4.4 Global Top Players DNA & RNA Oligonucleotides Headquarters and Area Served
4.5 Key Players DNA & RNA Oligonucleotides Product Solution and Service
4.6 Competitive Status
4.6.1 DNA & RNA Oligonucleotides Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eurofins Scientific
5.1.1 Eurofins Scientific Profile
5.1.2 Eurofins Scientific Main Business
5.1.3 Eurofins Scientific DNA & RNA Oligonucleotides Products, Services and Solutions
5.1.4 Eurofins Scientific DNA & RNA Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.1.5 Eurofins Scientific Recent Developments
5.2 Natera
5.2.1 Natera Profile
5.2.2 Natera Main Business
5.2.3 Natera DNA & RNA Oligonucleotides Products, Services and Solutions
5.2.4 Natera DNA & RNA Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.2.5 Natera Recent Developments
5.3 BGI
5.3.1 BGI Profile
5.3.2 BGI Main Business
5.3.3 BGI DNA & RNA Oligonucleotides Products, Services and Solutions
5.3.4 BGI DNA & RNA Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.3.5 Illumina Recent Developments
5.4 Illumina
5.4.1 Illumina Profile
5.4.2 Illumina Main Business
5.4.3 Illumina DNA & RNA Oligonucleotides Products, Services and Solutions
5.4.4 Illumina DNA & RNA Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.4.5 Illumina Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche DNA & RNA Oligonucleotides Products, Services and Solutions
5.5.4 Roche DNA & RNA Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 LabCorp
5.6.1 LabCorp Profile
5.6.2 LabCorp Main Business
5.6.3 LabCorp DNA & RNA Oligonucleotides Products, Services and Solutions
5.6.4 LabCorp DNA & RNA Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.6.5 LabCorp Recent Developments
5.7 Berry Genomics
5.7.1 Berry Genomics Profile
5.7.2 Berry Genomics Main Business
5.7.3 Berry Genomics DNA & RNA Oligonucleotides Products, Services and Solutions
5.7.4 Berry Genomics DNA & RNA Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.7.5 Berry Genomics Recent Developments
5.8 Brooks Life Sciences
5.8.1 Brooks Life Sciences Profile
5.8.2 Brooks Life Sciences Main Business
5.8.3 Brooks Life Sciences DNA & RNA Oligonucleotides Products, Services and Solutions
5.8.4 Brooks Life Sciences DNA & RNA Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.8.5 Brooks Life Sciences Recent Developments
5.9 Macrogen
5.9.1 Macrogen Profile
5.9.2 Macrogen Main Business
5.9.3 Macrogen DNA & RNA Oligonucleotides Products, Services and Solutions
5.9.4 Macrogen DNA & RNA Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.9.5 Macrogen Recent Developments
5.10 Genotypic Technology
5.10.1 Genotypic Technology Profile
5.10.2 Genotypic Technology Main Business
5.10.3 Genotypic Technology DNA & RNA Oligonucleotides Products, Services and Solutions
5.10.4 Genotypic Technology DNA & RNA Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.10.5 Genotypic Technology Recent Developments
5.11 Dna Link
5.11.1 Dna Link Profile
5.11.2 Dna Link Main Business
5.11.3 Dna Link DNA & RNA Oligonucleotides Products, Services and Solutions
5.11.4 Dna Link DNA & RNA Oligonucleotides Revenue (US$ Million) & (2018-2023)
5.11.5 Dna Link Recent Developments
6 North America
6.1 North America DNA & RNA Oligonucleotides Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe DNA & RNA Oligonucleotides Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America DNA & RNA Oligonucleotides Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 DNA & RNA Oligonucleotides Market Dynamics
11.1 DNA & RNA Oligonucleotides Industry Trends
11.2 DNA & RNA Oligonucleotides Market Drivers
11.3 DNA & RNA Oligonucleotides Market Challenges
11.4 DNA & RNA Oligonucleotides Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
